EP Patent

EP3498697A1 — Novel salts and polymorphs of lesinurad

Assigned to Quimica Sintetica SA · Expires 2019-06-19 · 7y expired

What this patent protects

New salts and polymorphs of lesinurad, having the formula (I) reported below, are provided.Also described are the processes for the preparation of said solid forms.

USPTO Abstract

New salts and polymorphs of lesinurad, having the formula (I) reported below, are provided.Also described are the processes for the preparation of said solid forms.

Drugs covered by this patent

Patent Metadata

Patent number
EP3498697A1
Jurisdiction
EP
Classification
—
Expires
2019-06-19
Drug substance claim
No
Drug product claim
No
Assignee
Quimica Sintetica SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.